|1.||Prieto, Juan C: 23 articles (02/2015 - 07/2003)|
|2.||Carmena, María J: 23 articles (02/2015 - 07/2003)|
|3.||Delgado, Mario: 22 articles (01/2013 - 04/2003)|
|4.||Bajo, Ana M: 18 articles (02/2015 - 06/2005)|
|5.||Gonzalez-Rey, Elena: 16 articles (08/2010 - 09/2005)|
|6.||Sánchez-Chapado, Manuel: 14 articles (02/2015 - 06/2005)|
|7.||Gomariz, Rosa P: 13 articles (08/2015 - 04/2003)|
|8.||Juarranz, Yasmina: 13 articles (08/2015 - 01/2005)|
|9.||Fernández-Martínez, Ana B: 10 articles (02/2015 - 06/2005)|
|10.||Chorny, Alejo: 9 articles (05/2008 - 09/2005)|
09/01/1976 - "The demonstration of elevated levels of vasoactive intestinal polypeptide in both tumor and plasma and the ultrastructural description of endocrine granules may help to explain the pathophysiology in this case."
08/01/2010 - "Gamma-glutamyl 16-diaminopropane derivative of vasoactive intestinal peptide: a potent anti-oxidative agent for human epidermoid cancer cells."
07/01/2010 - "The receptors for vasoactive intestinal peptide (VIP), VPAC1-, VPAC2-, and PAC1-receptor are overexpressed by various tumor cells. "
10/01/2009 - "Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors."
09/01/2007 - "[A case report of vasoactive intestinal Peptide tumors]."
12/01/2006 - "Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide."
01/01/2015 - "Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice."
10/01/2009 - "Vasoactive intestinal peptide ameliorates intestinal barrier disruption associated with Citrobacter rodentium-induced colitis."
12/01/2006 - "The aim of this study was to investigate the therapeutic effect of vasoactive intestinal peptide-induced regulatory DCs (DC(VIP)) in a murine model of colitis. "
08/01/2015 - "Epithelial responsiveness to vasoactive intestinal peptide was increased after enteric glial function was blocked in mice with colitis. "
|3.||Ganglion Cysts (Ganglion)
08/01/1979 - "Immunohistochemical studies have demonstrated that immunoreactive vasoactive intestinal peptide is present in, and restricted to, the differentiating and mature ganglion cells in a variety of normal and neoplastic neural tissues. "
11/06/2013 - "These GFP-ir fibers with bouton-like varicosities were frequently observed to surround ganglion cells immunoreactive for vasoactive intestinal polypeptide, a marker for postganglionic parasympathetic neurons. "
01/01/2004 - "A week after HGN crush, axon collaterals grew from parasympathetic pelvic ganglion neurons, shown by the presence of numerous varicose fibers immunostained for vasoactive intestinal peptide (VIP). "
06/01/2002 - "Vasoactive intestinal peptide was found in cell bodies and fibers of the palatine ganglion but appeared to provide a sparse innervation to the naris dilator muscle only. "
10/07/1996 - "However, only 0-12% of viscerofugal neurons labelled in the rectum from the inferior mesenteric ganglion or intermesenteric nerves contained immunoreactivity to vasoactive intestinal peptide (VIP). "
|4.||Asthma (Bronchial Asthma)
01/01/1995 - "Design and development of a vasoactive intestinal peptide analog as a novel therapeutic for bronchial asthma."
01/01/1986 - "In two studies vasoactive intestinal peptide (VIP) was administered intravenously to two groups of eight in-patient volunteers recovering from severe acute asthma. "
01/01/2001 - "Vasoactive intestinal polypeptide as mediator of asthma."
08/01/1996 - "This suggests that bronchodilator NEP substrates, such as vasoactive intestinal polypeptide or atrial natriuretic peptide, modulate EIB in patients with asthma."
01/01/1991 - "Vasoactive intestinal polypeptide (VIP) in asthma."
|5.||Septic Shock (Toxic Shock Syndrome)
02/01/2007 - "To investigate the protective effects of vasoactive intestinal peptide (VIP) on septic shock rats and explore its possible mechanism. "
02/01/2007 - "[Protective effects of vasoactive intestinal peptide on septic shock rats]."
05/01/2006 - "[Protective effects of vasoactive intestinal peptide on intestinal lesions induced by endotoxic shock in rat]."
01/01/2000 - "Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock."
11/01/1988 - "Vasoactive intestinal peptide (VIP) is a potent vasodilator that has been reported to be a mediator of the hemodynamic changes in endotoxin-induced hypodynamic septic shock. "
|2.||Calcitonin Gene-Related Peptide
|5.||Somatostatin (Somatotropin Release-Inhibiting Factor)
|7.||Serotonin (5 Hydroxytryptamine)
|9.||Phosphopyruvate Hydratase (Enolase)